DROUET, Christian, Alberto LÓPEZ-LERA, Arije GHANNAM, Margarita LÓPEZ-TRASCASA, Sven CICHON, Denise PONARD, Faidra PARSOPOULOU, Hana GROMBIŘÍKOVÁ, Tomáš FREIBERGER, Matija RIJAVEC, Camila L VERONEZ, João Bosco PESQUERO and Anastasios E GERMENIS. SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE. FRONTIERS IN ALLERGY. Lausanne: Frontiers, 2022, vol. 3, March 2022, p. 1-17. ISSN 2673-6101. Available from: https://dx.doi.org/10.3389/falgy.2022.835503.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE
Authors DROUET, Christian (guarantor), Alberto LÓPEZ-LERA, Arije GHANNAM, Margarita LÓPEZ-TRASCASA, Sven CICHON, Denise PONARD, Faidra PARSOPOULOU, Hana GROMBIŘÍKOVÁ (203 Czech Republic, belonging to the institution), Tomáš FREIBERGER (203 Czech Republic, belonging to the institution), Matija RIJAVEC, Camila L VERONEZ, João Bosco PESQUERO and Anastasios E GERMENIS.
Edition FRONTIERS IN ALLERGY, Lausanne, Frontiers, 2022, 2673-6101.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30225 Allergy
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/22:00128685
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3389/falgy.2022.835503
UT WoS 000994423400001
Keywords in English C1 Inhibitor; C1-INH-HAE; SERPING1 gene; angioedema; genetic variation; hereditary–diagnosis; serpin function; serpinopathy
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 8/7/2024 14:21.
Abstract
Hereditary angioedema with C1 Inhibitor deficiency (C1-INH-HAE) is caused by a constellation of variants of the SERPING1 gene (n = 809; 1,494 pedigrees), accounting for 86.8% of HAE families, showing a pronounced mutagenic liability of SERPING1 and pertaining to 5.6% de novo variants. C1-INH is the major control serpin of the kallikrein-kinin system (KKS). In addition, C1-INH controls complement C1 and plasminogen activation, both systems contributing to inflammation. Recognizing the failed control of C1s protease or KKS provides the diagnosis of C1-INH-HAE. SERPING1 variants usually behave in an autosomal-dominant character with an incomplete penetrance and a low prevalence. A great majority of variants (809/893; 90.5%) that were introduced into online database have been considered as pathogenic/likely pathogenic. Haploinsufficiency is a common feature in C1-INH-HAE where a dominant-negative variant product impacts the wild-type allele and renders it inactive. Small (36.2%) and large (8.3%) deletions/duplications are common, with exon 4 as the most affected one. Point substitutions with missense variants (32.2%) are of interest for the serpin structure-function relationship. Canonical splice sites can be affected by variants within introns and exons also (14.3%). For noncanonical sequences, exon skipping has been confirmed by splicing analyses of patients' blood-derived RNAs (n = 25). Exonic variants (n = 6) can affect exon splicing. Rare deep-intron variants (n = 6), putatively acting as pseudo-exon activating mutations, have been characterized as pathogenic. Some variants have been characterized as benign/likely benign/of uncertain significance (n = 74). This category includes some homozygous (n = 10) or compound heterozygous variants (n = 11). They are presenting with minor allele frequency (MAF) below 0.00002 (i.e., lower than C1-INH-HAE frequency), and may be quantitatively unable to cause haploinsufficiency. Rare benign variants could contribute as disease modifiers. Gonadal mosaicism in C1-INH-HAE is rare and must be distinguished from a de novo variant. Situations with paternal or maternal disomy have been recorded (n = 3). Genotypes must be interpreted with biological investigation fitting with C1-INH expression and typing. Any SERPING1 variant reminiscent of the dysfunctional phenotype of serpin with multimerization or latency should be identified as serpinopathy.
Links
MUNI/A/1099/2019, interní kód MUName: Faktory nespecifické imunity u některých imunopatologických stavů (Acronym: nespecif. imunita)
Investor: Masaryk University, Category A
MUNI/A/1244/2021, interní kód MUName: Vrozená imunita a její abnormality v rozvoji imunopatologických stavů
Investor: Masaryk University
NV18-05-00330, research and development projectName: Genetická determinace závažnosti otoků podmíněných bradykininem u pacientů s hereditárním angioedémem
Investor: Ministry of Health of the CR, Genetic determination of bradykinin-mediated angioedema severity in patients with hereditary angioedema
PrintDisplayed: 21/8/2024 12:57